Clinical Trial Update: Comparison Of Efficacy And Safety Of Thalidomide Vs Hydroxyurea In Thalassemia Patients: A Single-Centre Pilot Study. [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial comparing the efficacy and safety of thalidomide versus hydroxyurea in patients with beta-thalassemia was completed at a single center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Beta-Thalassemia | Phase 2 | Status: COMPLETED